It is important to remember that the MCF-7 line is positive estrogen receptor breast cancer, and MDA-MB-231 is a triple-negative breast tumor line, a subtype characterized by the absence of hormonal receptors and HER-2, for which there is no defined treatment protocol. The gene discussed is ESR1; the disease is breast carcinoma.